Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy.
Belge Bilgin G, Bilgin C, Childs DS, Orme JJ, Burkett BJ, Packard AT, Johnson DR, Thorpe MP, Riaz IB, Halfdanarson TR, Johnson GB, Sartor O, Kendi AT.
Belge Bilgin G, et al. Among authors: packard at.
Front Oncol. 2024 Jul 12;14:1386718. doi: 10.3389/fonc.2024.1386718. eCollection 2024.
Front Oncol. 2024.
PMID: 39070149
Free PMC article.